Deltagen

Deltagen EBIT Margin

The EBIT Margin (Operating Margin) of Deltagen (DGEN) as of Nov 3, 2026 is -5.97 %. In the previous year, EBIT Margin (Operating Margin) was 29.28 % — a change of -120.40% (lower).

EBIT Margin

-5.97 %

YoY

-120.40%

Last updated:

EBIT Margin (Operating Margin) of Deltagen is 2015 -5.97 % . EBIT Margin (Operating Margin) of Deltagen was 2014 29.28 % . It decreases by -120.40% lower compared to the previous year.

Deltagen's operating (EBIT) margin stands at -6.0%, up from -315.5% several years earlier.

The Deltagen EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2008
0.02 USD
Jan 1, 2009
-0.52 USD
Jan 1, 2010
-0.35 USD
Jan 1, 2011
-3.16 USD
Jan 1, 2012
-0.05 USD
Jan 1, 2013
0.11 USD
Jan 1, 2014
29.28 USD
Jan 1, 2015
-5.97 USD
The Deltagen EBIT Margin history
YEAREBIT MarginYoY
-5.97 %-120.40%
29.28 %+26,615.78%
0.11 %-317.94%
-0.05 %-98.41%
-3.16 %+803.37%
-0.35 %-32.58%
-0.52 %-2,296.85%
0.02 %-131.81%
-0.07 %-118.33%
0.40 %+487.82%
0.07 %-98.87%
6.10 %+15.84%
5.26 %-68.94%
16.95 %+51.88%
11.16 %-217.13%
-9.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Deltagen Stock analysis

What does Deltagen do? Deltagen Inc is a leading biotechnology company focused on drug discovery and the development of novel therapies. The company was founded in 1996 by a group of scientists and is headquartered in San Francisco, California. The founders recognized the potential of genetic research and developed innovative technologies for identifying target molecules for drug development. Over the years, they acquired numerous patents and heavily invested in research and development. Deltagen Inc specializes in two core areas: genomic research and drug discovery. In the field of genomic research, the company offers services for systematic analysis of gene functions. This includes identification of target molecules, development of drug candidates, and validation of drug targets. In the field of drug discovery, Deltagen Inc focuses on developing novel therapies for a variety of diseases. The company utilizes advanced technologies and innovative research approaches to identify and validate potential drug candidates. Their goal is to develop groundbreaking medications that significantly improve patient's lives. Another important area of Deltagen Inc is diagnostics. The company offers tests for various diseases, including cancer, neurological disorders, and metabolic disorders. These tests are based on genetic analysis and can aid in early detection of diseases and enable targeted treatment. Deltagen Inc works closely with the pharmaceutical industry and other partners to advance drug development. The company has established numerous collaborations and licensing agreements with leading pharmaceutical companies and offers a wide range of products and services for drug development. Deltagen Inc's products include antibodies and other biomolecules that can be used for the treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. The company also develops innovative therapy approaches based on RNA interference and gene therapy. Deltagen Inc is a company with a strong culture of innovation, constantly striving to explore new avenues and evolve. The founders and the entire team have a passion for science and the potential it has for improving the health and well-being of people. Deltagen Inc emphasizes close collaboration with customers and partners to jointly develop and market innovative solutions. The company takes pride in being part of an industry that contributes to improving the lives of patients worldwide. Deltagen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Deltagen stock

EBIT Margin (Operating Margin) of Deltagen is -5.97 % in 2015.

EBIT Margin (Operating Margin) of Deltagen changed from 29.28 % to -5.97 %, representing a -120.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Deltagen since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Deltagen with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Deltagen

All Key Metrics — Deltagen